(Q35058619)

6 August 2017

1 reference

title

Regression of left ventricular hypertrophy: hoping for a longer life (English)

1 reference

left ventricular hypertrophy

6 August 2017

main subject

1 reference

Andrew Sharp

1

1 reference

6 August 2017

Jamil Mayet

series ordinal

2

1 reference

6 August 2017

publication date

1 September 2002

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

141-144

1 reference

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Myocardial fibrosis: functional significance and regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Clinical studies of drug reversal of hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Ethnic differences in the hypertensive heart and 24-hour blood pressure profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2002.032

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2002.032

1 reference

6 August 2017

1 reference